BPSR did a con call about long haulers and they have a promising Therapeutic. a question was asked about Phase III as they are at the end of Phase IIb and they said they would need as many as 30,000 people for Phase III study. I guess that will be the same for GNBT but wonder if that will all be done in China or will Phase III study also be conducted in the US?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links